Nifty
Sensex
:
:
11810.85
40252.03
43.10 (0.37%)
106.53 (0.27%)

Hospital & Healthcare Services

Rating :
47/99  (View)

BSE: 532843 | NSE: FORTIS

125.90
0.15 (0.12%)
27-Oct-2020 | 11:14AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  125.75
  •  126.45
  •  125.70
  •  125.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  93410
  •  117.60
  •  169.00
  •  113.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,489.82
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,577.85
  • N/A
  • 1.47

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 31.17%
  • 4.89%
  • 12.20%
  • FII
  • DII
  • Others
  • 41.04%
  • 8.64%
  • 2.06%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.97
  • 1.98
  • 0.52

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.12
  • 24.47
  • 17.42

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -10.04
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.10
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.57
  • 1.70
  • 1.55

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.71
  • 25.97
  • 27.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
606
1,138
-47%
1,113
1,184
-6%
1,169
1,103
6%
1,212
1,140
6%
Expenses
709
996
-29%
987
1,069
-8%
1,012
1,065
-5%
1,028
1,076
-4%
EBITDA
-103
142
-
126
115
9%
157
38
313%
184
64
188%
EBIDTM
-17%
12%
14%
10%
13%
3%
15%
6%
Other Income
4
20
-77%
18
10
84%
5
43
-89%
10
11
-8%
Interest
41
51
-19%
57
65
-12%
48
111
-57%
49
85
-42%
Depreciation
72
71
1%
80
60
34%
70
60
16%
71
56
27%
PBT
-211
49
-
7
0
1527%
44
-218
-
127
-162
-
Tax
-20
-26
-
50
183
-72%
117
-20
-
6
-15
-
PAT
-191
75
-
-43
-182
-
-73
-197
-
121
-147
-
PATM
-31%
7%
7%
-15%
-6%
-18%
10%
-13%
EPS
-2.53
1.00
-
-0.57
-2.41
-
-0.97
-2.61
-
1.60
-1.95
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
4,100
4,632
4,469
4,561
4,574
4,199
3,966
3,492
6,058
2,986
1,496
Net Sales Growth
-10%
4%
-2%
0%
9%
6%
14%
-42%
103%
100%
 
Cost Of Goods Sold
5,280
964
928
999
998
942
935
881
777
639
393
Gross Profit
-1,180
3,668
3,541
3,562
3,576
3,257
3,031
2,611
5,281
2,347
1,103
GP Margin
-29%
79%
79%
78%
78%
78%
76%
75%
87%
79%
74%
Total Expenditure
3,736
4,023
4,244
4,288
4,221
3,995
3,835
3,440
5,405
2,581
1,436
Power & Fuel Cost
-
104
100
95
101
108
103
94
87
69
42
% Of Sales
-
2%
2%
2%
2%
3%
3%
3%
1%
2%
3%
Employee Cost
-
916
914
899
905
818
765
695
628
551
273
% Of Sales
-
20%
20%
20%
20%
19%
19%
20%
10%
18%
18%
Manufacturing Exp.
-
1,405
1,537
1,588
1,663
1,620
1,475
1,236
892
668
390
% Of Sales
-
30%
34%
35%
36%
39%
37%
35%
15%
22%
26%
General & Admin Exp.
-
542
627
514
474
482
481
406
385
322
277
% Of Sales
-
12%
14%
11%
10%
11%
12%
12%
6%
11%
18%
Selling & Distn. Exp.
-
0
0
0
0
0
0
0
0
0
0
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
92
142
195
84
47
106
127
2,637
333
0
% Of Sales
-
2%
3%
4%
2%
1%
3%
4%
44%
11%
4%
EBITDA
364
610
225
273
353
204
131
52
653
405
60
EBITDA Margin
9%
13%
5%
6%
8%
5%
3%
1%
11%
14%
4%
Other Income
38
53
92
140
166
156
96
167
151
176
101
Interest
195
205
337
258
229
133
152
250
634
297
250
Depreciation
292
292
233
239
222
225
235
183
371
182
104
PBT
-33
165
-252
-84
67
2
-160
-214
-200
101
-194
Tax
153
148
114
23
72
-8
5
11
231
41
15
Tax Rate
-459%
65%
-24%
-2%
110%
20%
-3%
-5%
29%
38%
10%
PAT
-187
46
-663
-1,062
-64
-54
-178
-234
492
71
132
PAT before Minority Interest
-198
79
-588
-988
-7
-31
-164
-229
564
67
136
Minority Interest
-11
-34
-75
-75
-58
-23
-14
-5
-73
4
-4
PAT Margin
-5%
1%
-15%
-23%
-1%
-1%
-4%
-7%
8%
2%
9%
PAT Growth
0%
107%
38%
-1,550%
-19%
70%
24%
-148%
594%
-46%
 
EPS
-2.47
0.61
-8.79
-14.07
-0.85
-0.72
-2.36
-3.10
6.51
0.94
1.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
6,661
6,601
4,062
5,143
4,461
4,718
4,952
4,381
3,256
3,291
Share Capital
755
755
519
518
763
1,133
1,133
1,080
410
409
Total Reserves
5,902
5,822
3,515
4,608
3,690
3,585
3,820
3,301
2,847
2,879
Non-Current Liabilities
1,170
782
876
1,247
704
1,112
1,787
5,003
3,791
983
Secured Loans
953
636
477
795
273
473
533
2,213
1,459
478
Unsecured Loans
1
1
472
484
594
532
1,126
2,604
2,214
456
Long Term Provisions
76
66
64
55
43
47
44
41
32
18
Current Liabilities
2,579
3,591
2,134
1,926
1,450
1,602
972
3,108
4,499
455
Trade Payables
598
754
763
589
561
529
482
879
756
169
Other Current Liabilities
1,537
1,522
850
577
322
983
412
1,768
848
219
Short Term Borrowings
363
1,231
452
680
512
27
32
346
2,836
51
Short Term Provisions
82
85
69
80
56
63
46
115
59
16
Total Liabilities
10,955
11,486
8,327
9,484
7,007
7,585
7,851
13,514
12,378
4,759
Net Block
8,802
8,477
4,992
5,419
3,642
4,218
4,147
9,274
9,180
2,524
Gross Block
9,946
9,384
5,642
5,865
3,871
5,390
5,152
10,297
10,142
3,016
Accumulated Depreciation
1,144
907
646
446
229
1,173
1,006
1,023
962
492
Non Current Assets
10,014
9,819
7,045
7,709
5,592
5,947
5,810
10,958
10,466
3,363
Capital Work in Progress
204
450
226
268
226
228
147
244
566
258
Non Current Investment
175
190
1,397
1,486
883
848
824
798
235
36
Long Term Loans & Adv.
703
597
382
481
496
638
684
574
437
543
Other Non Current Assets
131
105
48
54
346
15
8
68
48
2
Current Assets
940
1,667
1,282
1,775
1,415
1,636
2,040
2,556
1,912
1,397
Current Investments
0
79
335
392
569
616
993
389
6
62
Inventories
78
57
67
62
60
64
62
92
80
26
Sundry Debtors
459
542
470
473
444
409
441
663
546
194
Cash & Bank
266
856
220
546
167
190
259
512
415
163
Other Current Assets
138
152
185
145
174
358
286
899
865
951
Short Term Loans & Adv.
-16
-20
5
157
89
269
223
821
755
919
Net Current Assets
-1,638
-1,924
-853
-152
-36
34
1,069
-552
-2,587
942
Total Assets
10,955
11,486
8,327
9,484
7,007
7,585
7,851
13,514
12,378
4,759

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
172
-179
493
966
195
24
479
1,644
298
-82
PBT
239
-110
-912
552
34
-137
149
731
113
-206
Adjustment
418
427
1,372
342
249
309
455
938
346
233
Changes in Working Capital
-146
-247
53
184
44
-28
-20
224
-54
-34
Cash after chg. in Working capital
511
69
513
1,078
327
143
584
1,893
405
-7
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-339
-248
-20
-111
-132
-119
-105
-250
-107
-75
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
60
-3,323
-335
-1,002
113
213
2,669
-1,003
-910
2,178
Net Fixed Assets
-686
8
-18
-56
92
-80
-92
-77
-65
-15
Net Investments
157
-4,652
-55
-1,174
-17
384
-389
-96
-779
-135
Others
589
1,322
-262
229
38
-91
3,150
-830
-65
2,328
Cash from Financing Activity
-862
4,257
-672
259
-354
-304
-3,217
-74
691
-3,240
Net Cash Inflow / Outflow
-630
755
-515
224
-47
-67
-69
567
79
-1,144
Opening Cash & Equivalents
634
-165
348
123
179
249
485
405
161
1,305
Closing Cash & Equivalent
7
634
-165
348
142
183
249
485
405
161

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
88
87
78
99
90
87
93
91
72
72
ROA
1%
-6%
-11%
0%
0%
-2%
-2%
4%
1%
2%
ROE
1%
-11%
-22%
0%
-1%
-4%
-6%
17%
2%
6%
ROCE
5%
-2%
-11%
4%
2%
0%
0%
14%
6%
7%
Fixed Asset Turnover
0.48
0.59
0.79
0.94
0.91
0.75
0.45
0.59
0.45
0.54
Receivable days
39
41
38
37
37
39
58
36
45
43
Inventory Days
5
5
5
5
5
6
8
5
6
6
Payable days
66
74
64
54
53
52
80
108
80
55
Cash Conversion Cycle
-22
-28
-21
-12
-11
-7
-14
-66
-28
-6
Total Debt/Equity
0.20
0.30
0.49
0.43
0.34
0.38
0.38
1.48
2.36
0.37
Interest Cover
2
0
-3
1
1
0
0
2
1
2

News Update


  • Fortis Healthcare reports consolidated net loss of Rs 179 crore in Q1
    17th Aug 2020, 10:45 AM

    Total consolidated income of the company decreased by 47.28% at Rs 610.40 crore for Q1FY21

    Read More
  • Fortis Healthcare - Quarterly Results
    14th Aug 2020, 17:55 PM

    Read More
  • Fortis Healthcare planning to focus on geographies
    10th Aug 2020, 09:31 AM

    The company planning to focus on geographies such as National Capital Region, Mumbai, Bengaluru, and Kolkata where it can build further on its strengths in FY21

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.